genomic markers of early progression without for advanced breast cancer in the paloma-3 trial在试验中具有或没有上早期进展基因组标志物.pdf
文本预览下载声明
PresentedByBenOLearyat2019ASCOAnnualMeeting
Pre
显示全部
文档详情
相似文档
-
the discovery of putative urine markers for the specific detection of prostate tumor by integrative mining of public genomic profiles假定的尿液标志物的发现的具体检测前列腺肿瘤的综合矿业公共基因组资料.pdf
The Discovery of Putative Urine Markers for the Specific
Detection of Prostate Tumor by Integrative Mining of
Public Genomic Profiles
1,3. 2. 1,3 2 1
Min Chen , Kai Wang , Li
-
sputum-based molecular biomarkers for the early detection of lung cancer limitations and promisesputum-based分子生物标志物对肺癌的早期检测的局限性和承诺.pdf
Cancers 2011, 3, 2975-2989; doi:10.3390/cancers3032975
OPEN ACCESS
-
geparolaa randomized phase ii trial with her2-negative early breast cancer bcGeparolaa随机试验阴性早期乳腺癌.pdf
-
the ectopic expression of brca1 is associated with genesis, progression, and prognosis of breast cancer in young patientsbrca1的异位表达与起源、发展,并在年轻患者乳腺癌的预后.pdf
Zhang et al. Diagnostic Pathology 2012, 7:181
/content/7/1/181
RESEARCH Open Access
The ectopic expression of BRCA1 is associated
with genesis, progression, and prognosis of
breast can
-
synergy or independence deciphering the interaction of hla class i and nk cell kir alleles in early hiv-1 disease progression协同或独立解密hla的交互类hiv - 1月初我和nk细胞吉珥等位基因疾病进展.pdf
Opinion
Synergy or Independence? Deciphering the
Interaction of HLA Class I and NK Cell KIR
Alleles in Early HIV-1 Disease Progression
*
Jason D. Barbour , Uma Sriram, Stacy J. Caillier, Jay A. Levy, Frederick M. Hecht, Jorge R. Oksenberg
Introduction
-
tailoring the process of informed consent in genetic and genomic research裁剪基因和基因组研究的知情同意的过程.pdf
Rotimi and Marshall Genome Medicine 2010, 2:20
/content/2/3/20
CO M M E N TA R Y
Tailoring the process of informed consent in
genetic and genomic research
1 2
Charles N Rotimi* and Patricia A Marshall*
-
the feasibility of a single-blinded fast-track pragmatic randomised controlled trial of a complex intervention for breathlessness in advanced disease单盲快速实用的随机对照试验的可行性先进复杂干预呼吸困难的疾病.pdf
BMC Palliative Care BioMed Central
Research article Open Access
The fe
-
comparison of 6q25 breast cancer hits from asian and european genome wide association studies in the breast cancer association consortium (bcac)对比6 q25乳腺癌的访问量,来自亚洲和欧洲的全基因组关联研究乳腺癌协会联盟(bcac).pdf
Comparison of 6q25 Breast Cancer Hits from Asian and
European Genome Wide Association Studies in the
Breast Cancer Association Consortium (BCAC)
Rebecca Hein1,2*, Melanie Maranian3, John L. Hopper4, Miroslaw K. Kapuscinski4, Melissa C. Southey5,
Daniel J. Park6, Marjanka K Schm
-
systematic review of the diagnostic performance of serum markers of liver fibrosis in alcoholic liver disease系统回顾诊断性能的酒精性肝病的肝纤维化血清标志物.pdf
Parkes et al. Comparative Hepatology 2012, 11:5
/content/11/1/5
REVIEW Open Access
Systematic review of the diagnostic performance
of serum markers of liver fibrosis in alcoholic l
-
the importance of identity-by-state information for the accuracy of genomic selectionidentity-by-state信息的重要性基因组选择的准确性.pdf
Luan et al. Genetics Selection Evolution 2012, 44:28 Ge n e t i c s
/content/44/1/28 Se l e c t i o n
-
the importance of information on relatives for the prediction of genomic breeding values and the implications for the makeup of reference data sets in livestock breeding schemes信息的重要性的亲戚基因组育种值的预测和对参考数据集的组成在家畜育种方案.pdf
Clark et al. Genetics Selection Evolution 2012, 44:4 Ge n e t i c s
/content/44/1/4 Se l e c t i o n
-
colorimetric immunoassay for detection of tumor markers比色法检测肿瘤标志物.pdf
Int. J. Mol. Sci. 2010, 11, 5077-5094; doi:10.3390/ijm
OPEN ACCESS
International Journal of
-
the effect of a dna repair gene on cellular invasiveness xrcc3 over-expression in breast cancer cellsdna修复基因的效应细胞侵袭性xrcc3乳腺癌细胞中表达.pdf
The Effect of a DNA Repair Gene on Cellular Invasiveness:
Xrcc3 Over-Expression in Breast Cancer Cells
1 ´ 4 1 1
Veronica L. Martinez-Marignac , Amelie Rodrigue , Da
-
biomarkers for early detection of malignant mesothelioma diagnostic and therapeutic application生物标志物早期诊断恶性间皮瘤的诊断和治疗的应用程序.pdf
Cancers 2010, 2, 523-548; doi:10.3390/cancers2020523
OPEN ACCESS
cancers
-
ykl-40—a protein in the field of translational medicine a role as a biomarker in cancer patientsykl-40-a蛋白质领域的转化医学在癌症患者作为生物标志物.pdf
Cancers 2010, 2, 1453-1491; doi:10.3390/cancers2031453
OPEN ACCESS
cancers